BTA - Biota Holdings

[moreld]

Biota's revenue mix for the last five years.
With earnings due and $56.7 million in anticipated royalties I decided now was a good time to look back at Biota’s revenue over the last five years.

 

[pixel]

It seems that somebody realised $67M isn't a bad royalty income after all.
The recent sell-off looks definitely overdone.

Disclosure: I hold already and will average up if current support holds.
Targets $1.24 and $1.35.

 

[nunthewiser]

Cheers for the chart Pixel.

I too have taken a small position in this as a POSITION trade.

The tech and fundamental stars have alligned on this one for a bit and on a personal view i figured it was worth a play.

Stoplosses do apply as with all other trades.

Have a good day

 

[nunthewiser]

Looks like its just you and me Pixel ..... Nice move this morning so far.

You still in ?.....

Should show up on a few TECH radars soon if not already

 

[pixel]

Looks like its just you and me Pixel ..... Nice move this morning so far.

You still in ?.....

Should show up on a few TECH radars soon if not already

absolutely, Gero
And I did top up sub-$1. Holding enough now.
And it seems some techies have indeed noticed and begun buying up.

 

[nunthewiser]

FWIW.

I have exited my BTA postion today for a small profit.(99.5) It hit my trailing stop and they were the rules i set.
I will re-enter on a clear break of 105.will also look very closely if it makes the 90 to mid 90,s area
I could be wrong on my exit but thems the breaks, i can always enter another day.

Top of watchlist for now.

 

[desmo]

Any fundamentalists got some news behind the recent SP rise? I'm a techie and a holder. Wondering if it's a glitch or the start of something bigger?

 

[subi1]

Any fundamentalists got some news behind the recent SP rise? I'm a techie and a holder. Wondering if it's a glitch or the start of something bigger?

I think it is flu season in the Northern Hemsiphere and they have 2 products being sold(maybe 3 if you include Intravenous Zanamavir).

Relenza through GLAXO
Inavir through Daiichi Sankyo

Biota has also been seeking development funding in the U.S. through BARDA. I think it was mentioned in the AGM releases?

I think there is plenty of info around if you want to look including articles in the press.

 

[pixel]

FWIW.

I have exited my BTA postion today for a small profit.(99.5) It hit my trailing stop and they were the rules i set.
I will re-enter on a clear break of 105.will also look very closely if it makes the 90 to mid 90,s area
I could be wrong on my exit but thems the breaks, i can always enter another day.

Top of watchlist for now.

That was a good exit, nun
But since then, we also got a few good entries and re-entries; some of them I took, but through the entire 6-7 months, I held on to a core position to avoid having to scramble for stock in a case like the latest breakout.


Have taken some profit (about a quarter posi) in case we revisit those gaps down there. But it's even money those gaps can remain open for months, if not years.

PS: Sorry desmo, I'm a techie myself and can only guess at fundamental reasons. Subi1 could be on the right track, but the chart should show us what's happening regardless why.

 

[Market Depth]

Been trading BTA for many many years. It does 'Bounce Around' a far bit Might be time for me to bank a little bit over the coming weeks

 

[Market Depth]

Are you still on this one Tech? It's pushing higher.

 

[tech/a]

Yes I was!!

$3000 profit turned into a $450 loss by the time my stop
(The second one) got hit just as I got back First one went at $1.42 but the second which i hadnt adjusted up laid open till hit!
The joy of the Building industry---when site calls You must go!

But on the + side AAD +$1875.
Not all tears.

 

[suhm]

Not to sure why it got hammered so hard, dropped a bundle today, still in profit though. I guess maybe the market was expecting them to announce a licenscing deal but not sure why that would be so as that would be a price sensitive announcement and the loss was expected given the low royalty numbers for relenza and high expenditure for clinical trials.
I'm expecting it to be a painful few months and for my profits to disappear given the price action. Probably shouldn't fall in love with a stock but can't really sell out now given any LANI ROW deal should net it a motza given that it is already outselling relenza and tamiflu in Japan from launch.

 

[Market Depth]

Caught me off gaurd somewhat today as well. As soon as it opened lower on a gap down I was scrambling for the sell button. Did I mention it bounces around a fair bit?

 

[Sean K]

Is this still being traded in Aust?

With the flu epidemic hitting the US I thought they'd be all over the news.

 

[pixel]

Is this still being traded in Aust?

With the flu epidemic hitting the US I thought they'd be all over the news.

http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=bta&timeframe=D&period=M6
they sold out to America and are delisted from the ASX.
Very much p!$$ed-off, all of us who supported them through the lean years.
(Someone warned me several years ago that t he directors were not very loyal to their shareholders. 'nuff said.)

 

[burglar]

http://www.asx.com.au/asx/statistics/announcements.do?by=asxCode&asxCode=bta&timeframe=D&period=M6
they sold out to America and are delisted from the ASX.
Very much p!$$ed-off, all of us who supported them through the lean years.
(Someone warned me several years ago that t he directors were not very loyal to their shareholders. 'nuff said.)

Once delisted it is difficult to find charts, prices & reports!

 

[rcm617]

It's trading under BOTA on the Nasdaq. Has been fairly uninspiring over there since listing on the Nasdaq, although has been ticking up the last few days.
http://finance.yahoo.com/q?s=BOTA

 

[pixel]

It's trading under BOTA on the Nasdaq. Has been fairly uninspiring over there since listing on the Nasdaq, although has been ticking up the last few days.
http://finance.yahoo.com/q?s=BOTA

That would be thanks to the Australian Taxpayer, who gave them some $4M for past R&D.
No Relenza sales, and Lanivir royalties amounted to peanuts.

Anyway, I am currently not trading anything outside Australia; almost 2000 shares and hundreds of options give me far more opportunities than I can possibly handle. When they announced they'd desert us, I picked a reasonable time and price point to exit. Still a big loss from the last lot, although, over the years, I've just about broken even. That experience has only reinforced my resolve not to believe in funnymentals, opinions, rosy outlooks, and forecasts - the reasons I held on to a few BTA, no matter how small, against the chart.